ATI LPN
Pharmacology and the Nursing Process 10th Edition Test Bank
Chapter 35 Questions
Question 1 of 5
A patient is to receive testosterone therapy via a transdermal patch. He asks the nurse, 'I'd rather take a pill. Why am I getting a patch?' Which response by the nurse is correct?
Correct Answer: C
Rationale: Transdermal testosterone patches provide better absorption due to bypassing the high first-pass metabolism of oral forms. Patches are changed daily, not weekly, and do not necessarily reduce side effects or mandate injections as the only alternative.
Question 2 of 5
When a male patient is receiving androgen therapy, the nurse will monitor for signs of excessive androgens such as
Correct Answer: A
Rationale: Excessive androgens can cause fluid retention as an adverse effect, leading to edema or weight gain. Dehydration, restlessness, and visual changes are not typical effects of androgen excess.
Question 3 of 5
A patient is receiving finasteride for treatment of benign prostatic hyperplasia. The nurse will tell him that a possible effect of this medication is
Correct Answer: B
Rationale: Finasteride, a 5-alpha-reductase inhibitor, reduces prostate size in benign prostatic hyperplasia and can promote hair growth as a side effect, often used for male pattern baldness. It does not cause alopecia, urinary retention, or prostate enlargement.
Question 4 of 5
The nurse is reviewing orders for a female patient and notes an order for the androgen testosterone. Based on this finding, which of these is correct?
Correct Answer: C
Rationale: Testosterone is used in women for inoperable breast cancer to suppress tumor growth. It is not indicated for fibrocystic breast disease or hereditary angioedema, and the order is appropriate for this condition.
Question 5 of 5
A 21-year-old male athlete admits to using androgenic steroids. The nurse tells him that which of these is a possible adverse effect of these drugs?
Correct Answer: A
Rationale: Androgenic steroids can cause severe liver damage, including peliosis hepatis and hepatic neoplasms. Renal failure, heart failure, and Stevens-Johnson syndrome are not commonly associated with anabolic steroid use.